Viewing Study NCT05704933


Ignite Creation Date: 2025-12-25 @ 3:02 AM
Ignite Modification Date: 2025-12-28 @ 9:56 PM
Study NCT ID: NCT05704933
Status: COMPLETED
Last Update Posted: 2025-10-20
First Post: 2023-01-20
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Pilot Study of Nivolumab w/Ipilimumab or Relatlimab in Surgically Resectable Melanoma Brain Metastases
Sponsor: H. Lee Moffitt Cancer Center and Research Institute
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module